HK1153143A1 - Pharmaceutical composition for the treatment of type 2 diabetes in mammals including human beings - Google Patents
Pharmaceutical composition for the treatment of type 2 diabetes in mammals including human beingsInfo
- Publication number
- HK1153143A1 HK1153143A1 HK11107352.4A HK11107352A HK1153143A1 HK 1153143 A1 HK1153143 A1 HK 1153143A1 HK 11107352 A HK11107352 A HK 11107352A HK 1153143 A1 HK1153143 A1 HK 1153143A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- diabetes
- treatment
- type
- pharmaceutical composition
- human beings
- Prior art date
Links
- 241000282414 Homo sapiens Species 0.000 title 1
- 241000124008 Mammalia Species 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101403973A CN101961336B (zh) | 2009-07-21 | 2009-07-21 | 治疗哺乳动物包括人2型糖尿病的药物组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1153143A1 true HK1153143A1 (en) | 2012-03-23 |
Family
ID=43498754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK11107352.4A HK1153143A1 (en) | 2009-07-21 | 2011-07-15 | Pharmaceutical composition for the treatment of type 2 diabetes in mammals including human beings |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN101961336B (fr) |
| HK (1) | HK1153143A1 (fr) |
| WO (1) | WO2011009360A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108144065B (zh) * | 2016-12-06 | 2023-05-16 | 江苏恒瑞医药股份有限公司 | 一种dpp-4抑制剂的药物组合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101287495A (zh) * | 2005-06-10 | 2008-10-15 | 诺瓦提斯公司 | Dpp-iv抑制剂和格列酮的直接压片的制剂和制备方法 |
| CN101468988A (zh) * | 2007-12-26 | 2009-07-01 | 上海恒瑞医药有限公司 | 哌嗪类衍生物,其制备方法及其在医药上的应用 |
-
2009
- 2009-07-21 CN CN2009101403973A patent/CN101961336B/zh active Active
-
2010
- 2010-06-23 WO PCT/CN2010/074309 patent/WO2011009360A1/fr active Application Filing
-
2011
- 2011-07-15 HK HK11107352.4A patent/HK1153143A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101961336A (zh) | 2011-02-02 |
| CN101961336B (zh) | 2012-05-30 |
| WO2011009360A1 (fr) | 2011-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1163500A1 (en) | Pharmaceutical composition for the treatment of heart diseases | |
| IL207546A0 (en) | Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases | |
| IL225198A (en) | Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes | |
| IL224544B (en) | Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound | |
| IL220684A (en) | Anaphylactic therapy for Alzheimer's and the aging brain | |
| IL210810A0 (en) | Compositions for the treatment of pain and/or inflamtion | |
| IL206080A0 (en) | Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases | |
| HUE038785T2 (hu) | Hagyományos kínai gyógyszerkészítmény szív- és érrendszeri betegségek kezelésére | |
| HK1141447A1 (en) | Pharmaceutical composition for the treatment of proliferative diseases | |
| PT2358373E (pt) | Composição injetável de polidesoxirribonucleotídeos para o tratamento de doenças osteoarticulares | |
| IL223289A (en) | The history of triazine and pharmaceutical preparations containing them for the treatment of type 2 diabetes | |
| GB0903158D0 (en) | Cosmetic or pharmaceutical preparation for the skin | |
| EP2306824A4 (fr) | Administration par ionophorèse de curcumine et analogues de curcumine destinés au traitement de la maladie d'alzheimer | |
| GB0909297D0 (en) | Composition for the treatment of skin conditions | |
| PT2842555T (pt) | Derivados-alfa de ácidos gordos cis-monoinsaturados para uso como medicamentos no tratamento de diabetes | |
| IL213703A (en) | Compounds for the treatment of pain and other diseases | |
| ZA201009072B (en) | Pharmaceutical composition for the treatment of premature ejaculation | |
| EP2231148A4 (fr) | Composition pharmaceutique utilisée dans le traitement et la prévention d'une maladie cardiaque | |
| GB0715790D0 (en) | Drug combination for the treatment of sialorrhoea | |
| HK1156844A1 (en) | Pharmaceutical composition 271 271 | |
| IL200753A (en) | Pharmaceutical preparation containing ib – meca for the treatment of psoriasis | |
| HK1147700A1 (en) | Pharmaceutical composition for the treatment of type 2 diabetes in mammals including man | |
| EP2402342A4 (fr) | Composition pharmaceutique servant a traiter le diabete de type 2 | |
| PL2344166T3 (pl) | Kompozycja farmaceutyczna do leczenia zaburzeń w postaci podrażnień żołądkowo-jelitowych | |
| PL2307380T3 (pl) | Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230723 |